Down-regulation of alphav integrin by retroviral delivery of small interfering RNA reduces multicellular resistance of HT29

Cancer Lett. 2009 Nov 1;284(2):182-8. doi: 10.1016/j.canlet.2009.04.023. Epub 2009 May 10.

Abstract

Since multicellular resistance (MCR) has been shown to be as adhesion-dependent, the role of alphav integrin in MCR of HT29 was investigated in this paper. Down-regulation of alphav integrin reduced MCR to oxaliplatin, but did not detectably change the drug sensitivity of monolayers. Down-regulation of alphav integrin decreased phosphorylated NF-kappaB p65 and increased phosphorylated JNK2 in multicellular spheroids. Cell-cell adhesion and cell-cell junctions in multicellular spheroids resembled the in vivo situation. Since force, including adhesion, can activate alphav integrin, cell-cell contact may contribute to activation of alphav integrin, through which increasing phosphorylated p65 and decreasing phosphorylated JNK2 takes part in MCR.

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenocarcinoma / therapy
  • Animals
  • Antineoplastic Agents, Alkylating / pharmacology
  • Cell Adhesion / drug effects
  • Cell Adhesion / physiology
  • Cell Line, Tumor / drug effects
  • Cell Line, Tumor / transplantation
  • Colonic Neoplasms / pathology*
  • Colonic Neoplasms / therapy
  • Down-Regulation / drug effects
  • Drug Resistance, Neoplasm / drug effects*
  • Genetic Therapy*
  • Genetic Vectors / pharmacology*
  • Genetic Vectors / therapeutic use
  • Integrin alphaV / biosynthesis
  • Integrin alphaV / genetics*
  • MAP Kinase Kinase 7 / metabolism
  • Mice
  • Neoplasm Proteins / metabolism
  • Organoplatinum Compounds / pharmacology
  • Oxaliplatin
  • Phosphorylation / drug effects
  • Phosphorylation / genetics
  • Protein Processing, Post-Translational / drug effects
  • Protein Processing, Post-Translational / genetics
  • RNA Interference*
  • RNA, Small Interfering / pharmacology*
  • Retroviridae / genetics*
  • Spheroids, Cellular / drug effects
  • Transcription Factor RelA / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents, Alkylating
  • Integrin alphaV
  • Neoplasm Proteins
  • Organoplatinum Compounds
  • RELA protein, human
  • RNA, Small Interfering
  • Transcription Factor RelA
  • Oxaliplatin
  • MAP Kinase Kinase 7
  • MAP2K7 protein, human